Coeliac Disease Trial, Recruiting (NCT06160323)

Coeliac Disease Trial, Recruiting NCT06160323 Sponsor: Chinese University of Hong Kong Condition: Coeliac Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06160323 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Coeliac Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older
You have been diagnosed with pancreatic cancer that cannot be removed by surgery
You have ongoing tumor-related pain in the central abdomen that is constant and has no other clear cause, rated at least 3 out of 10 on a pain scale
You are well enough to carry out at least 60% of normal daily activities (confirm with trial site)
You are already scheduled for an internal camera procedure (called an endoscopic ultrasound) to examine or take a small tissue sample from your pancreatic tumor

Who may not be able to join:

You have a known allergy to the local anesthetic bupivacaine or to alcohol
Your cancer may become operable after receiving pre-surgery treatment
Your expected survival is less than 3 months
You are already taking opioid-based painkillers (such as morphine or codeine) to manage your pain
You have previously had a nerve-blocking procedure for pain relief, either through the skin or via an internal camera procedure
Your pancreatic cancer has come back after you previously had surgery to remove a tumor
You have a blood clotting problem that cannot be corrected
You are unable or unwilling to give your formal agreement to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 852-35052627

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06160323

Sponsor: Chinese University of Hong Kong

Phase: Not Applicable

Status: Recruiting

Condition: Coeliac Disease

Trial contact: 852-35052627

More information: https://clinicaltrials.gov/study/NCT06160323

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older
You have been diagnosed with pancreatic cancer that cannot be removed by surgery
You have ongoing tumor-related pain in the central abdomen that is constant and has no other clear cause, rated at least 3 out of 10 on a pain scale
You are well enough to carry out at least 60% of normal daily activities (confirm with trial site)
You are already scheduled for an internal camera procedure (called an endoscopic ultrasound) to examine or take a small tissue sample from your pancreatic tumor

Who may not be able to join:

You have a known allergy to the local anesthetic bupivacaine or to alcohol
Your cancer may become operable after receiving pre-surgery treatment
Your expected survival is less than 3 months
You are already taking opioid-based painkillers (such as morphine or codeine) to manage your pain
You have previously had a nerve-blocking procedure for pain relief, either through the skin or via an internal camera procedure
Your pancreatic cancer has come back after you previously had surgery to remove a tumor
You have a blood clotting problem that cannot be corrected
You are unable or unwilling to give your formal agreement to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Chinese University of Hong Kong

Registry

ClinicalTrials.gov

Start date

10 November 2023

Est. completion

31 July 2027

Where this trial is recruiting

Hong Kong

Primary endpoints

The mean change in VAS pain score at 3 months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov